Highland Park, IL, United States of America

Dinah Abram

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dinah Abram: Innovator in Immunoassay Technology

Introduction

Dinah Abram is a notable inventor based in Highland Park, IL (US). She has made significant contributions to the field of immunoassays, particularly in the detection of Neisseria gonorrhoeae antigens. Her work is crucial in advancing clinical diagnostics and improving patient care.

Latest Patents

Dinah Abram holds a patent for an "Immunoassay for Neisseria gonorrhoeae antigens." This patent describes a solid phase immunoassay designed for the detection of Neisseria gonorrhoeae antigens in clinical specimens. The innovative aspect of her patent lies in the method of coating or adsorbing the antigens on a solid phase, which enhances the accuracy and efficiency of the detection process.

Career Highlights

Dinah is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. Her role at Abbott allows her to work on cutting-edge technologies that have a direct impact on public health. With her expertise, she contributes to the development of diagnostic tools that are essential for disease detection and management.

Collaborations

Dinah has collaborated with esteemed colleagues, including Alan S. Armstrong and John E. Herrmann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in their respective fields.

Conclusion

Dinah Abram's work in immunoassay technology exemplifies the impact of innovative thinking in healthcare. Her contributions not only enhance diagnostic capabilities but also pave the way for future advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…